Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AMCO United Holding's annualized ROCE % for the quarter that ended in Dec. 2025 was 99.60%.
AMCO United Holding (HKSE:00630) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
AMCO United Holding ROCE % Related Terms
AMCO United Holding ROCE % Historical Data
* Premium members only.
The historical data trend for AMCO United Holding's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMCO United Holding (HKSE:00630) has a ROCE % of 99.60% as of Dec. 2025.
Is AMCO United Holding's ROCE % too high?
AMCO United Holding's current ROCE % is 99.60%. The Medical Devices & Instruments industry median ROCE % is 2.65. AMCO United Holding's value of 99.60% is 3658.5% above this industry median. Overall, AMCO United Holding has a GF Score™ of 28/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AMCO United Holding's ROCE % compare to ISRG and BDX?
AMCO United Holding's ROCE % of 99.60% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.65. AMCO United Holding's value of 99.60% is 3658.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.65, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AMCO United Holding's current ROCE % of 99.60% is 3658.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMCO United Holding's current ROCE % is 99.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMCO United Holding stock overvalued right now?
Based on GuruFocus' analysis, AMCO United Holding (HKSE:00630) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.12, compared to a current price of HK$0.11 — trading 8.3% below its estimated fair value. The current ROCE % is 99.60% and 3658.5% above the Medical Devices & Instruments industry median of 2.65. AMCO United Holding's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For AMCO United Holding (HKSE:00630), the current ROCE % is 99.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AMCO United Holding (HKSE:00630) Overvalued in 2026?
Based on GuruFocus' analysis, AMCO United Holding stock appears to be undervalued.
The current stock price of HK$0.11 is trading 8.3% below its estimated GF Value™ of HK$0.12.
GuruFocus considers AMCO United Holding to be Fairly Valued.
Key valuation signals for HKSE:00630:
ROCE %: 99.60%
GF Value™: HK$0.12 vs. price of HK$0.11 (8.3% below fair value)
Industry Position: 3658.5% above the Medical Devices & Instruments median
No single metric tells the full story. See the HKSE:00630 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AMCO United Holding Ltd is a Hong Kong-based investment holding company principally engaged in the manufacture and (i) sale of medical products; (ii) sale of plastic moulding products; (iii) provision of money lending; and (iv) investment in securities. The company operates its business through four segments: Medical Products Business; Plastic Products Business; Money Lending Business; and Securities Investment Business. It generates the majority of its revenue from the Medical Products Business segment. Geographically, it generates the majority of its revenue from the PRC.
28GF Score
Get the complete analysis for HKSE:00630
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00630 has been successfully added to your 
